Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2-Reference-Cited by-同舟云学术

Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2

Published:2015-04 Issue:4 Volume:27 Page:489-501
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Zhu Eric F.,Gai Shuning A.,Opel Cary F.,Kwan Byron H.,Surana Rishi,Mihm Martin C.,Kauke Monique J.,Moynihan Kelly D.,Angelini Alessandro,Williams Robert T.,Stephan Matthias T.,Kim Jacob S.,Yaffe Michael B.,Irvine Darrell J.,Weiner Louis M.,Dranoff Glenn,Wittrup K. Dane

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference71 articles.

1. Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response;Abès;Blood,2010

2. The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues;Allavena;Immunol. Rev.,2000

3. Perspective— FcRn transports albumin: relevance to immunology and medicine;Anderson;Trends Immunol.,2006

4. Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma;Bajorin;Cancer Res.,1990

5. Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer;Baley;J. Steroid Biochem. Mol. Biol.,1995

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells;Journal for ImmunoTherapy of Cancer;2024-06

2. Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity;Cancer Immunology Research;2024-05-30

3. Nuclear-targeted chimeric peptide nanorods to amplify innate anti-tumor immunity through localized DNA damage and STING activation;Journal of Controlled Release;2024-05

4. The application of antibody-based agents in cancer therapy based on their mechanisms of action;Fundamental Research;2024-04

5. Synergistic therapeutic strategies and engineered nanoparticles for anti-vascular endothelial growth factor therapy in cancer;Life Sciences;2024-03